Zelboraf 240 mg (Vemurafenib 240 mg per tablet) by Roche.
Indications: Unresectable or metastatic melanoma with BRAF V600 mutation; Erdheim-Chester disease.
Administration: Oral: 960 mg (4 tablets) twice daily.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Vemurafenib 240 mg per tablet — BRAF V600 inhibitor. |
| Strength & pack | 56 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |